Stocklytics Platform
Asset logo for symbol VVOS
Vivos Therapeutics
VVOS59
$2.33arrow_drop_up11.00%$0.22
High Growth
Penny Stock
Asset logo for symbol VVOS
VVOS59

$2.33

arrow_drop_up11.00%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Vivos Therapeutics (VVOS) Stocklytics Forecast

According to our AI and machine learning algorithms, we have generated a price prediction for Vivos Therapeutics, Inc. (VVOS) stock. Based on our analysis, we anticipate that VVOS stock will experience positive growth in the coming years. Our forecast suggests that the stock price of VVOS will progressively increase over time. In particular, we predict that by 2023, the stock price of Vivos Therapeutics, Inc. will reach a higher level than its current value. With this forecast, investors may consider VVOS as a potential investment opportunity.
In addition to our AI and machine learning predictions, we have also gathered data from various analysts to determine the price target for VVOS stock. Based on analyst ratings and forecasts, it is expected that the price of Vivos Therapeutics, Inc. (VVOS) will increase in the future. Analysts predict that the stock price of VVOS will continue to rise, reaching a higher level by 2023. This suggests that VVOS may be a good buy for investors looking to maximize their returns.
add Vivos Therapeutics to watchlist

Keep an eye on Vivos Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Vivos Therapeutics (VVOS) stock?

Analysts have set a target price of $6.25 for Vivos Therapeutics (VVOS), based on forecasts from 2 analysts. The predicted price range extends from a high of $10 to a low of $2.5. This represents a potential increase of up to 329.18% and a decrease of 7.3% from the current price of $2.33. These forecasts are as of 2021 Jan 05.
help

What are the analyst ratings for Vivos Therapeutics (VVOS) stock?

The analyst ratings for Vivos Therapeutics (VVOS) are distributed as follows: 2 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 3 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Vivos Therapeutics.
help

What is the AI price prediction for Vivos Therapeutics (VVOS) stock?

At present, there is no AI or machine-learning-based price prediction available for Vivos Therapeutics (VVOS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level